Weight-neutral antidepressants
Weight-neutral antidepressants are the ones least likely to move your weight much in either direction. No antidepressant is guaranteed to be weight-neutral, and the gaps between the common ones are small. In a large US study of eight common antidepressants, bupropion was linked with the least weight gain. Paroxetine and duloxetine were linked with slightly more, though the differences were small. Mirtazapine and older tricyclics such as amitriptyline are more likely to cause weight gain. Depression itself can change appetite and weight in either direction.
Also called: Weight neutral antidepressants, Antidepressants that cause weight loss.
Written by Alena Kozlova, PhD, from published studies and prescribing information.
Definition medically reviewed by Dr. Jason Tan, Consultant Psychiatrist, on November 11, 2026, this definition only. Next review: November 11, 2027.
The figures here come from US labels and US medical records. Approved uses and products differ in other countries.
Which antidepressants are weight-neutral?
None of them fully, and every gap between the common ones is under half a kilogram. A 2024 study in Annals of Internal Medicine followed 183,118 patients across eight US health systems and compared common antidepressants with sertraline at 6 months. Bupropion and fluoxetine came out closest to neutral, and escitalopram, paroxetine and duloxetine sat above the rest.
Two things to hold alongside the numbers. The study read medical records rather than randomly assigning treatment, so people who stayed on one medication may differ from people who did not. And it compared these medications against each other, so it says nothing about how much weight anyone gained in total.
- Bupropion: came out 0.22 kg lighter than sertraline, with a 15% lower risk of gaining at least 5% of starting weight. Across the eight medications it showed the least weight gain.
- Fluoxetine: came out the same as sertraline. The estimate was 0.07 kg lighter, in a range running from 0.19 kg lighter to 0.04 kg heavier, so no difference was found.
- Citalopram and venlafaxine: came out 0.12 kg and 0.17 kg heavier than sertraline.
- Duloxetine, paroxetine and escitalopram: came out 0.34 kg, 0.37 kg and 0.41 kg heavier than sertraline, with a 10% to 15% higher risk of gaining at least 5% of starting weight.
Do any antidepressants cause weight loss?
Bupropion is the one with weight loss written into its US label. In depression trials, 14% of people on 300 mg a day and 19% on 400 mg a day lost more than 5 pounds, against 6% on placebo, and the label describes a dose-related decrease in body weight. It holds up over a longer stretch too: in trials of up to 6 months in people taking it to prevent seasonal depression, 23% lost more than 5 pounds against 11% on placebo. The same label rules bupropion out for anyone with a current or past diagnosis of bulimia or anorexia nervosa, because seizures were seen more often in those patients, so weight loss is not a reason to ask for it if you have that history.
Fluoxetine comes second, in a smaller way. Its label reports loss of appetite in 11% of people against 2% on placebo in depression trials, and weight loss in 1.4% against 0.5%. The same label notes that significant weight loss, above all in people who are already underweight, can be an unwanted result of treatment.
No antidepressant is approved in the US as a weight loss medicine on its own. Bupropion is one of the two ingredients in Contrave, a separate medication approved for weight management in adults.
Which antidepressant causes the most weight gain?
Mirtazapine, by its own label. In US trials, appetite increase was reported by 17% of people on mirtazapine against 2% on placebo, weight gain by 12% against 2%, and a gain of 7% or more of body weight by 7.5% against none on placebo. Those are a different size of number from the gaps between the SSRIs above.
Why am I gaining weight on an antidepressant?
Sometimes because the depression is lifting. NIMH lists changes in appetite and unplanned weight changes among the symptoms of depression, so an appetite coming back can show up on the scale and look like the medication. Food, movement, other medicines and conditions such as a thyroid problem sit in the same picture, and your prescriber is the one who can sort out which of them is in play.
Is it worth switching antidepressants because of weight?
It can be, and your prescriber decides it with you, because those figures are averages across thousands of people and you are one. A switch has its own costs: withdrawal symptoms from the medication you leave, and weeks of waiting to learn whether the new one holds your mood. Weight that keeps climbing is a reason to raise the subject at your next appointment, not a reason to stop a medication on your own.
What to do
Rather than watching the scale, notice what sits around the weight: appetite, energy, sleep and how your clothes fit, and write down the date of any dose change. Bring your prescriber a steady change rather than one day, with when it started and what else changed around then. Ask what the options are for your medication, and whether a change of medication or help with the weight itself fits your situation. If your mood keeps dropping, tell your prescriber. If you are having thoughts of harming yourself, contact emergency services or a crisis line straight away. In the US, call or text 988. In the UK, call Samaritans on 116 123. Elsewhere, find a crisis line near you.
Read about bupropion
How withClaro helps
- Log how you feel each day, next to the dose you took
- Share a PDF report with your prescriber before your appointment
Get the withClaro app on the App Store
Related terms
Sources
- Petimar J, Young JG, Yu H, Rifas-Shiman SL, Daley MF, Heerman WJ, Janicke DM, Jones WS, Lewis KH, Lin PD, Prentice C, Merriman JW, Toh S, Block JP. Medication-induced weight change across common antidepressant treatments: a target trial emulation study. Annals of Internal Medicine, 2024.
- U.S. Food and Drug Administration. Wellbutrin XL (bupropion extended-release tablets): prescribing information. FDA / DailyMed, 2026.
- U.S. Food and Drug Administration. Prozac (fluoxetine): prescribing information. FDA / DailyMed, 2026.
- U.S. Food and Drug Administration. Remeron and RemeronSolTab (mirtazapine): prescribing information. FDA / DailyMed, 2021.
- U.S. Food and Drug Administration. Contrave (naltrexone and bupropion extended-release tablets): prescribing information. FDA / DailyMed, 2025.
- National Institute of Mental Health. Depression (NIH Publication No. 24-MH-8079). NIMH (nimh.nih.gov), 2024.
All glossary terms